Evidence map›Paper›PMID 39648502›Full record

ArticleScience progress

Evaluation of the therapeutic efficacy of renal artery stenting in patients with atherosclerotic renal artery stenosis.

Qiuyue Shi, Min Mao, Jing Chang, Xin Li, Yanwei Li

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiuyue ShiDepartment of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Min MaoDepartment of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0003-4720-2892
Jing ChangDepartment of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0002-5119-535X
Xin LiDepartment of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yanwei LiDepartment of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIt is currently controversial whether renal artery stenting is beneficial for the clinical outcomes of atherosclerotic renal artery stenosis (ARAS) patients. The study aims to evaluate whether blood pressure (BP) and renal function improve in ARAS patients after stenting.

methodsA retrospective study was conducted on 78 ARAS patients who underwent renal artery stenting at the First Affiliated Hospital of Chongqing Medical University from January 2013 to June 2024. BP, the number of oral antihypertensive medications, renal function, and adverse events were analyzed before and after stenting.

resultsA total of 90 stents were implanted. The median follow-up time was 1.59 years. From 24 hours post-operation, significant decline in BP were observed. During follow-up, systolic BP decreased by 24.27 mmHg (95% CI: 16.54-32.00;

conclusionsRenal artery stenting might significantly reduce BP and improve renal function in ARAS patients, particularly those with mild renal impairment, which still requires prospective multicenter studies to confirm.

Indexed as

AtherosclerosisBlood PressureRenal Artery ObstructionStentsAgedAntihypertensive AgentsFemaleGlomerular Filtration RateHumansKidneyMaleMiddle AgedRenal ArteryRetrospective StudiesTreatment OutcomeAntihypertensive AgentsAtherosclerotic renal artery stenosisblood pressurerenal artery stentingrenal functiontreatment

Identifiers

PMID39648502
PMCPMC11626679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.